Langerhans cells and lymphocyte subsets in human gastrointestinal carcinomas. An immunohistological study on frozen

C S Papadimitriou1, G Datseris, J S Costopoulos

  • 1Department of Pathology, School of Medicine, Aristotelian University of Thessaloniki, Greece.

Insights

Langerhans cells in gastric and colonic carcinomas correlate with T-cell density, suggesting their role in immune response against cancer. This study highlights Langerhans cells

Area of Science:

  • Immunology
  • Oncology
  • Gastroenterology

Background:

  • Langerhans cells are key immune cells in mucosal tissues.
  • Their role in gastrointestinal carcinomas is not fully understood.
  • T-cell subsets (CD4, CD8) are crucial in anti-tumor immunity.

Purpose of the Study:

  • To investigate the presence and significance of Langerhans cells in human gastric and colonic carcinomas.
  • To correlate Langerhans cell density with T-cell infiltration (CD4, CD8).
  • To elucidate the potential role of Langerhans cells in anti-tumor immune responses in gastrointestinal cancers.

Main Methods:

  • Immunohistochemical analysis of 38 gastric and 40 colonic carcinoma samples.
  • Identification of Langerhans cells (CD1+), helper T-cells (CD4+), and suppressor T-cells (CD8+) using monoclonal antibodies.
  • Quantification of cell densities per high power field.
  • Statistical analysis to determine correlations.

Main Results:

  • No significant association between Langerhans cell numbers and tumor histology, differentiation, or metastasis.
  • A significant positive correlation (p < 0.05) was found between Langerhans cell density and the infiltration of T-cells, particularly CD4+ T-cells.
  • Langerhans cell numbers were significantly related to the density of CD4 and CD8 cell infiltrations in both gastric and colonic carcinomas.

Conclusions:

  • Langerhans cells are present in gastric and colonic carcinomas.
  • Their numbers are linked to T-cell infiltration, supporting their role as antigen-presenting cells.
  • Langerhans cells likely contribute to T-cell activation against gastrointestinal cancer cells.

Related Concept Videos